1977 B.Sc. University of Edinburgh, Scotland. 1984: M.Sc. University of Warwick, UK. 1988 Ph.D. University of Warwick, UK.

Fielding, C.et al. 2017. Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation. eLife 6 (10.7554/eLife.22206) pdf Murrell, I.et al. 2016. Genetic stability of BAC-deerived human cytomegalovirus during culture in vitro. Journal of Virology 90(8), pp. 3929-3943. (10.1128/JVI.02858-15) pdf Pjechová, M.et al. 2015. Adenoviral vectors in gene therapy. Klinicka onkologie 28(Suppl), pp. 2S75-2S80. (10.14735/amko20152S75) Wilkinson, G.et al. 2015. Human cytomegalovirus: taking the strain. Medical Microbiology and Immunology 204(3), pp. 273-284. (10.1007/s00430-015-0411-4) pdf Hsu, J.et al. 2015. Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141. PLoS Pathogens 11(4), article number: e1004811. (10.1371/journal.ppat.1004811) Stack, G.et al. 2015. CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue. PLoS Pathogens 11(2), article number: e1004641. (10.1371/journal.ppat.1004641) pdf McSharry, B.et al. 2015. Abrogation of the interferon response promotes more efficient human cytomegalovirus replication. Journal of Virology 89(2), pp. 1479-1483. (10.1128/JVI.02988-14) Raybould, R.et al. 2014. HPV integration detection in CaSki and SiHa using detection of integrated papillomavirus sequences and restriction-site PCR. Journal of Virological Methods 206, pp. 51-54. (10.1016/j.jviromet.2014.05.017)